Morgan Stanley Maintains Evelo Biosciences (EVLO) Equal-Weight Recommendation

Fintel reports that on July 26, 2023, Morgan Stanley maintained coverage of Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight recommendation.

admin